奥拉迪约2021年最新价格，奥拉迪约多少钱？

Orladeyo is the first targeted oral therapy approved to prevent the onset of hereditary angioedema HAE. Its approval will bring significant progress in the treatment of patients with hereditary angioedema HAE and will help reduce the treatment burden on patients. Today let’s take a look at the latest price of Oladi in 2021. How much does Oladi cost?

Currently, Orladeyo is not on the market in my country, let alone medical insurance. If patients want Orladeyo, they can obtain the drug through domestic professional overseas medical service agencies (such as Medical Companion Travel). The price is not fixed due to exchange rate fluctuations. For specific prices, please consult the Medical Companion Travel Service.

Recommended dose of Oradejo: Take one capsule (150 mg) once daily with food. Patients should not increase or decrease the dosage of the drug without authorization during treatment with Orladeyo. Increasing the dosage of the drug will not make the condition improve quickly, but will lead to adverse reactions. Therefore, patients should strictly follow the doctor's diagnosis and treatment recommendations and should not use medication without authorization. Orladeyo capsules should not be used to treat acute attacks of hereditary angioedema (HAE).

In the pivotal Phase 3 APeX-2 trial, BioCryst significantly reduced the number of hereditary angioedema HAE attacks over 24 weeks and continued through week 48. Patients who completed the 48-week trial experienced a significant reduction in the frequency of hereditary angioedema HAE attacks, from an average of 2.9 attacks/month at baseline to an average of 1 attack/month.

Completion of another long-term open-label APeX-S study reduced the frequency of HAE attacks in patients with hereditary angioedema to an average of 0.8 episodes per month. It can be seen that the therapeutic effect of Orladeyo capsules is very significant, and the successful development of this drug is good news for many patients.

Oradejo is a plasma kallikrein inhibitor that binds to plasma kallikrein and inhibits its proteolytic activity.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.